Please rate this video

EMN 2018 | Predicting long-term outcomes in myeloma: MRD

Please rate this video

Philip McCarthy

Philip McCarthy, MD, of Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses new strategies for clinical trial design in multiple myeloma (MM). Prof. McCarthy highlights measurable residual disease and covers the different techniques that can be used to determine this. This video was recorded at the 1st European Myeloma Network Meeting, in Turin, Italy.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter